Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Lexicon Pharmaceuticals (LXRX) Other Gross PP&E Adjustments (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with -$6.8 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments fell 48.68% to -$6.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.8 million through Dec 2025, down 48.68% year-over-year, with the annual reading at -$6.8 million for FY2025, 48.68% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$6.8 million at Lexicon Pharmaceuticals, up from -$7.5 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was -$4.5 million in Q2 2025, with the low at -$7.5 million in Q3 2025.
  • Average Other Gross PP&E Adjustments over 3 years is -$5.5 million, with a median of -$5.3 million recorded in 2024.
  • The sharpest move saw Other Gross PP&E Adjustments rose 23.05% in 2024, then plummeted 49.67% in 2025.
  • Over 3 years, Other Gross PP&E Adjustments stood at -$6.0 million in 2023, then increased by 23.05% to -$4.6 million in 2024, then plummeted by 48.68% to -$6.8 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$6.8 million, -$7.5 million, and -$4.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.